In vitro fertilization and breast cancer risk: A review

International Journal of Fertility and Women's Medicine

Volumn 50, Issue 6, 2005, Pages 259-266

  Salhab, M ^a   Al Sarakbi, W ^a   Mokbel, Kefah ^a,b,c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b The Princess Grace Hospital   (United Kingdom)

^c Princess Grace Hospital   (United Kingdom)

Author keywords

Breast cancer; Epidemiology; Fertility drugs; IVF; Ovulation induction

Indexed keywords

ANTIESTROGEN; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN; SEX HORMONE; FERTILITY PROMOTING AGENT;

BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ACTIVATION; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HORMONE ACTION; HORMONE RELEASE; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RECEPTOR BLOCKING; REVIEW; BREAST TUMOR; CASE CONTROL STUDY; FEMALE INFERTILITY; OVULATION INDUCTION; RISK FACTOR; WOMEN'S HEALTH;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; RISK FACTORS; WOMEN'S HEALTH;

EID: 33645912905     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Ries LAG, Kosary CL, Hankey BF, et al: SEER Cancer Statistics Review, 1973-1995. National Cancer Institute, Bethesda, MD, 1998.
2. Kelsey JL, Horn-Ross PL: Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15:7-16, 1993.
3. Lipworth L: Epidemiology of breast cancer. Eur J Cancer Prev 4:7-30, 1995.
4. Chandra A, Stephen EH: Impaired fecundity in the United States: 1982-1995. Fam Plann Perspect 30:34-42, 1998.
5. Wysowski DK: Use of fertility drugs in the United States, 1973 through 1991. Fertil Steril 60:1096-1098, 1993.
6. Glasier AF: Clomiphene citrate. BaillieAres Clin Obstet Gynaecol 4:491-501, 1990.
7. Clark JH, Markaverich BM: The agonistic-antagonistic properties of clomiphene: a review. Pharmacol Ther 15:467-519, 1981.
8. Mikkelson TJ, Kroboth PD, Cameron WJ, et al: Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril 46:392-396, 1986.
9. Fishel S, Jackson P: Follicular stimulation for high tech pregnancies: are we playing it safe? Br Med J 299:309-311, 1989.
10. Bolton PM: Bilateral breast cancer associated with clomiphene. Lancet 2:1176, 1977.
11. Gauthier E, Paoletti X, Clavel-Chapelon F, et al: Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 19:2216-2221, 2004.
12. Brinton LA, Scoccia B, Moghissi KS, et al: Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 19:2005-2013, 2004.
13. Lerner-Geva L, Geva E, Lessing JB, et al: The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer 13:23-27, 2003.
14. Doyle P, Maconochie N, Beral V, et al: Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 17:2209-2213, 2002.
15. Dor J, Lerner-Geva L, Rabinovici J, et al: Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 77:324-327, 2002.
16. Venn A, Watson L, Bruinsma F, et al: Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354:1586-1590, 1999.
17. Potashnik G, Lerner-Geva L, Genkin L, et al: Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 71:853-859, 1999.
18. Modan B, Ron E, Lerner-Geva L, et al: Cancer incidence in a cohort of infertile women. Am J Epidemiol 147:1038-1042, 1998.
19. Rossing MA, Daling JR, Weiss NS, et al: Risk of breast cancer in a cohort in infertile women. Gynecol Oncol 60:3-7, 1996.
20. Venn A, Watson L, Lumley J, et al: Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 346:995-1000, 1995.
21. Ron E, Lunenfeld B, Menczer J, et al: Cancer incidence in a cohort of infertile women. Am J Epidemiol 125:780-790, 1987.
22. Bernstein L, Hanisch R, Sullivan-Halley J, et al: Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 4:437-440, 1995.
23. Burkman RT, Tang MT, Malone KE, et al: Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril 79:844-851, 2003.
24. Braga C, Negri E, La Vecchia C, et al: Fertility treatment and risk of breast cancer. Hum Reprod 11:300-303, 1996.
25. Ricci E, Parazzini F, Negri E, et al: Fertility drugs and the risk of breast cancer. Hum Reprod 14:1653-1655, 1999.
26. Unkila-Kallio L, Leminen A, Tiitnen A, et al: Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases. Acta Obstet Gynecol Scand 76:177-181, 1997.
27. Brzezinski A, Peretz T, Mor-Yosef S, et al: Ovarian stimulation and breast cancer: is there a link? Gynecol Oncol 52:292-295, 1994.
28. Laing RW, Glaser MG, Barrett GS: A case of breast carcinoma in association with in vitro fertilization. J R Soc Med 82:503, 1989.
29. Key TJ, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24:29-43, 1988.
30. Pike MC, Spicer DV, Dahmoush LPM, et al: Estrogens, progesterons, normal breast cells proliferation, and breast cancer risk. Epidemiol Rev 15:17-35, 1993.
31. Colditz GA, Hankinson SE, Hunter DJ, et al: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332: 1589-1593, 1995.
32. Bergkvist L, Adami HO, Persson I, et al: The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293-297, 1989.
33. Mokbel K: Risk-reducing strategies for breast cancer-a review of recent literature. Int J Fertil 48:274-277, 2003.
34. Russo J, Russo IH: Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3:353-364, 1994.
35. Lambe M, Hsieh C, Trichopoulos D, et al: Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5-9, 1994.
36. Kriege M, Brekelmans CT, Boetes C, et al: Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition. Obstet Gynecol Surv 60:107-109, 2005.
37. Oktay K, Buyuk E, Davis O, et al: Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 18:90-95, 2003.
38. Siegelmann-Danieli N, Tamir A, Zohar H, et al: Breast cancer in women with recent exposure to fertility medications is associated with poor prognostic features. Ann Surg Oncol 10:1031-1038, 2003.